文献速递泌尿生殖与妇科肿瘤放疗姑息放疗与转移瘤

前列腺癌放疗或根治性前列腺切除术后急诊就诊的相对发生率

Relative Incidence of Emergency Department Visits After Treatment for Prostate Cancer With Radiation Therapy or Radical Prostatectomy.
PubMed 文献 · Pract Radiat Oncol · 2022-05-17

本研究采用自身对照病例系列设计,纳入2011至2020年在一家城市学术医疗中心接受放疗或根治性前列腺切除的前列腺癌患者,分析急诊就诊的相对发生率。结果显示,与未暴露期相比,根治性前列腺切除后急诊就诊率更高(RI 20.4),放疗总体RI为2.4,且不同放疗模式的RI存在差异。

要点

  • 根治性前列腺切除后急诊就诊相对发生率RI为20.4(95%CI 15.4-27.0,P<.001)。
  • 放疗总体急诊就诊相对发生率RI为2.4(95%CI 1.7-3.4,P<.001)。
  • 导致一次急诊就诊的需伤害人数根治性前列腺切除为17(95%CI 13-23),放疗总体为43(95%CI 25-126)。

核心结论

  • 急诊就诊的相对发生率因治疗类型而异,提示副作用严重程度不同。
  • 这些数据可能有助于选择治疗,并证明在真实世界结构化电子健康记录数据中使用自身对照病例系列设计来了解治疗副作用的可行性。

研究设计与样本

  • 采用自身对照病例系列研究设计,纳入2011至2020年在一家城市学术医疗中心接受放疗或根治性前列腺切除的前列腺癌患者。
  • 纳入标准为治疗前后均有至少6个月记录且至少有1次急诊就诊的患者。
  • 暴露期为治疗开始至治疗完成后1个月,非暴露期为所有其他有记录的时间。
  • 估计急诊就诊的相对发生率(RI),比较暴露期与非暴露期的发生率,并调整年龄。

主要发现

  • 在至少有1次急诊就诊的男性中,调整年龄后,与未暴露期相比,根治性前列腺切除后急诊就诊率更高(RI 20.4;95%CI 15.4-27.0;P<.001)。
  • 放疗总体急诊就诊率更高(RI 2.4;95%CI 1.7-3.4;P<.001)。
  • 调强放疗联合高剂量率近距离治疗急诊就诊率更高(RI 3.4;95%CI 1.7-6.8;P<.001)。
  • 立体定向体部放疗推量急诊就诊率更高(RI 7.1;95%CI 3.4-14.8;P<.001)。
  • 单纯高剂量率近距离治疗急诊就诊率更高(RI 16.3;95%CI 7.2-36.9;P<.001)。

关键数值与推荐

  • 导致一次急诊就诊的需伤害人数根治性前列腺切除为17(95%CI 13-23)。
  • 导致一次急诊就诊的需伤害人数放疗总体为43(95%CI 25-126),但因放疗模式而异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Side effect profiles play an important role in treatment decisions for localized prostate cancer. Emergency department (ED) visits, which may be due to side effects from treatment, can be measured in real-world, structured, electronic health record (EHR) data. The goal of this study was to determine whether treatments for localized prostate cancer are associated with ED visits, as a measure of side effects, using EHR data. METHODS AND MATERIALS: We used a self-controlled case series study design, including patients treated at an urban academic medical center with radiation therapy (RT) or radical prostatectomy (RP) for prostate cancer between 2011 and 2020 who had visits documented for ≥6 months before and after treatment and ≥1 ED visit. We estimated relative incidences (RI) of ED visits, comparing incidence in the exposed and unexposed periods, with the exposed period being between start of treatment and 1 month after completion, and the unexposed period consisting of all other documented time. RESULTS: Among men who had at least 1 ED visit and after adjusting for age, there were higher rates of ED visits after RP (RI, 20.4; 95% confidence interval [CI], 15.4-27.0; P < .001), RT overall (RI, 2.4; CI, 1.7-3.4; P < .001), intensity modulated radiation therapy with high dose-rate brachytherapy (RI, 3.4; CI, 1.7-6.8; P < .001) or stereotactic body radiation therapy boost (RI, 7.1; CI, 3.4-14.8; P < .001), and high dose rate brachytherapy alone (RI, 16.3; CI, 7.2-36.9; P < .001) compared with unexposed time. The number needed to harm to result in an ED visit was less for RP (17; CI, 13-23) than RT overall (43; CI, 25-126), but varied by RT modality. CONCLUSIONS: In summary, relative rates of ED visits vary by treatment type, suggesting differing severities of side effects. These data may aid in selecting treatments and demonstrate the feasibility of using the self-controlled case series study design on ED visits in real-world, structured EHR data to better understand side effects of treatment.

来源:Pract Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Alexander J, Beatty A, Mohamad O, et al. Relative Incidence of Emergency Department Visits After Treatment for Prostate Cancer With Radiation Therapy or Radical Prostatectomy. Pract Radiat Oncol. 2022. PMID: 35595216. doi:10.1016/j.prro.2022.05.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。